FGF19 GENE OVEREXPRESSION

Clinical trials for FGF19 GENE OVEREXPRESSION explained in plain language.

Never miss a new study

Get alerted when new FGF19 GENE OVEREXPRESSION trials appear

Sign up with your email to follow new studies for FGF19 GENE OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets genetic drivers in tough-to-treat cancers

Disease control Recruiting now

This is the first study in people testing an experimental pill called TYRA-430. It aims to find a safe dose and see if it can help control advanced liver cancer and other solid tumors that have specific genetic changes in the FGF/FGFR pathway. The study will enroll about 100 adul…

Matched conditions: FGF19 GENE OVEREXPRESSION

Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

FGF19 GENE OVEREXPRESSION

Get alerted when new FGF19 GENE OVEREXPRESSION trials appear

New pill targets genetic drivers in tough-to-treat cancers